News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
59 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (16220)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (1421)
Day
1 (213)
2 (187)
3 (160)
4 (139)
5 (74)
7 (52)
8 (139)
9 (151)
10 (114)
11 (133)
12 (59)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
Day
1
2
3
4
5
7
8
9
10
11
12
Insights
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
Strong science, lower costs and growing capital networks are putting Spain and Portugal on the biotech investment map, even as structural bottlenecks persist, according to two investors.
June 12, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Business
Novo hit with cybersecurity breach, urges vigilance among trial participants
Novo Nordisk said that the information affected by the breach shouldn’t allow third parties to “identify participants in our clinical trials” despite “unauthorized access” to patients’ personal data.
June 12, 2026
·
2 min read
·
Tristan Manalac
Neurodegenerative disease
Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win
The RNA-based medicine is one of a handful of antibody-oligonucleotide conjugates that Novartis acquired last October when it took over neuromuscular-focused Avidity Biosciences.
June 12, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
Amgen shores up Tavneos’ FDA defense with Duke data analysis
After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.
June 12, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA imposes import alert on Indian plant after inspectors flag GMP failings
Officials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant.
June 12, 2026
·
2 min read
·
Nick Paul Taylor
Layoff Tracker
Genentech R&D cuts include longtime top exec
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
June 12, 2026
·
59 min read
·
BioSpace Editorial Staff
Press Releases
Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
June 12, 2026
·
2 min read
Press Releases
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
June 12, 2026
·
2 min read
Press Releases
Crescent Biopharma Announces Grants of Inducement Awards - June 11, 2026
June 12, 2026
·
1 min read
Press Releases
Treace to Present at the Sidoti Small Cap Conference
June 12, 2026
·
2 min read
1 of 6
Next